AKS » Topics » PART IV

These excerpts taken from the AKS 10-K filed Feb 26, 2008.

PART II

 






Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%">AK Holding’s common stock has been listed on the New York Stock Exchange since April 5, 1995 (symbol: AKS). The table below sets forth, for the
calendar quarters indicated, the reported high and low sales prices of the common stock:

 




























































































2007

  High  Low

First Quarter

  $23.94  $16.13

Second Quarter

  $38.52  $23.49

Third Quarter

  $44.98  $27.90

Fourth Quarter

  $53.97  $39.10

2006

  High  Low

First Quarter

  $15.45  $7.58

Second Quarter

  $15.95  $11.11

Third Quarter

  $14.33  $11.57

Fourth Quarter

  $17.31  $11.62

As of February 22, 2008 there were 111,912,162 shares of common stock outstanding and held of
record by 5,374 stockholders. The closing stock price on February 22, 2008 was $50.79 per share. Because depositories, brokers and other nominees held many of these shares, the number of record holders is not representative of the number of
beneficial holders.

The payment of cash dividends is subject to a restrictive covenant contained in the instruments governing most of the
Company’s outstanding senior debt. The covenant allows the payment of dividends, if declared by the Board of Directors, and the redemption or purchase of shares of its outstanding capital stock, subject to a formula that reflects cumulative net
earnings. Prior to 2007 and since 2001, as a result of cumulative losses recorded over several years, the Company was not permitted under the formula to pay a cash dividend on its common stock. During the third quarter of 2007, the cumulative losses
calculated under the formula were eliminated due to the improved financial performance of the Company. Accordingly, a cash dividend is now permissible under the senior debt covenants. Restrictive covenants also are contained in the instruments
governing the Company’s $850.0 asset-based revolving credit facility. Under the credit facility covenants, dividends are not restricted unless availability under the credit facility falls below $150.0, at which point dividends would be limited
to $12.0 annually. Currently, the availability under the asset-based revolving credit facility significantly exceeds $150.0. Accordingly, there currently are no covenant restrictions on the Company’s ability to declare and pay a dividend to its
shareholders.

On January 22, 2008, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.05 per
share of common stock, payable on March 10, 2008, to shareholders of record on February 15, 2008.

The Company made no open
market purchases of any of its equity securities during the fourth quarter of 2007 or at any time during the year 2007. In April 2000, the Board of Directors authorized the Company to repurchase, from time to time, up to $100.0 of its outstanding
equity securities. Through September 2002, the Company expended $53.6 to purchase 3,702,600 shares of its common stock and all of the outstanding shares of its $3.625 cumulative convertible preferred stock after declaring and paying all current and
accrued dividends then outstanding. The Company’s ability to purchase shares under this authorization is subject to the same debt covenant discussed above that can restrict dividend payments. Beginning in 2002 and continuing until the third
quarter of 2007, the Company was not permitted as a result of this restrictive covenant to repurchase further shares under the April 2000 authorization. Since the third quarter of 2007, the Company could again repurchase shares, but has not yet done
so and will announce its intent to re-activate this share repurchase program before making future purchases.

There were no unregistered
sales of equity securities in the quarter ended December 31, 2007.

 


16







Table of Contents


PART IV

 

Item 15. Exhibits and Financial Statement Schedules.

(a) The list of exhibits and financial statements filed as part of this report is submitted as a separate section, the index to which is located on the following page. One financial statement schedule (Exhibit 99.1) is included.

(b) Exhibits:

List of exhibits begins on next page.

 

103


Table of Contents
This excerpt taken from the AKS 10-K filed Feb 27, 2007.

PART IV

 

Item 15. Exhibits and Financial Statement Schedules.

(a) The list of exhibits and financial statements filed as part of this report is submitted as a separate section, the index to which is located on the following page. One financial statement schedule (Exhibit 99.1) is included.

(b) Exhibits:

List of exhibits begins on next page.

 

100


Table of Contents
This excerpt taken from the AKS 10-K filed Mar 2, 2006.

PART IV

 

Item 15. Exhibits and Financial Statement Schedules.

 

(a) The list of exhibits and financial statements filed as part of this report is submitted as a separate section, the index to which is located on the following page. One financial statement schedule (Exhibit 99.1) is included.

 

(b) Exhibits:

 

List of exhibits begins on next page.

 

87


Table of Contents
This excerpt taken from the AKS 10-K filed Mar 8, 2005.

PART IV

 

Item 15. Exhibits and Financial Statement Schedules.

 

(a) The list of financial statements filed as part of this report is submitted as a separate section, the index to which is located on page 32. Financial statement schedules are omitted because of the absence of the conditions under which they are required or because the information is set forth in the financial statements or notes thereto.

 

(b) Exhibits:

 

List of exhibits begins on next page.

 

79


Table of Contents
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki